Skye Bioscience Inc (SKYE)

[nonewname1]

Thanks for the response,

Is the outlook for cannaboids derived from the plant really that bad? Tetra Bio touts their phase 2 ppp0002 drug for cancer pain being from the plant as having an "Advantage over approved synthetic THC" in the "Significant reduction of side effects in patients and stability at room temperature"

They say they've "Demonstrated that safety will be significantly
superior"

http://tetrabiopharma.com/wp-content/uploads/2017/05/Tetra-IR-presentation-Updated-May-2-2017.pdf ---pg 9

If the FDA softened up on their stance how difficult would it be for NMUS to pivot if they needed/wanted to? I'm guessing they would have to start over, and that we are mostly on board here for the synthetic stuff. Which should be ok at the very least in the short term I'm guessing as long as the FDA doesn't make big changes in the near future, and synthetic becomes viewed as less effective or less safe.

Thanks for any response, I appreciate you guys being willing to share what you've learned so far.